SE462043B - 1,3 oxazino 4,3-a isokinolinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner innehaallande dem - Google Patents

1,3 oxazino 4,3-a isokinolinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner innehaallande dem

Info

Publication number
SE462043B
SE462043B SE8405331A SE8405338A SE462043B SE 462043 B SE462043 B SE 462043B SE 8405331 A SE8405331 A SE 8405331A SE 8405338 A SE8405338 A SE 8405338A SE 462043 B SE462043 B SE 462043B
Authority
SE
Sweden
Prior art keywords
carbon atoms
formula
group
compound
alkyl
Prior art date
Application number
SE8405331A
Other languages
English (en)
Swedish (sv)
Other versions
SE8405338D0 (sv
Inventor
G Bernath
J Kobor
F Foloep
P Sohar
P Perjesi
E Ezer
G Hajos
E Palosi
L Denes
L Szporny
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SE8405338D0 publication Critical patent/SE8405338D0/xx
Publication of SE462043B publication Critical patent/SE462043B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE8405331A 1983-10-25 1984-10-25 1,3 oxazino 4,3-a isokinolinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner innehaallande dem SE462043B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU833654A HU190458B (en) 1983-10-25 1983-10-25 Process for preparing /1,3/ oxazino /4,3-a/ isoquinoline-derivatives

Publications (2)

Publication Number Publication Date
SE8405338D0 SE8405338D0 (sv) 1984-10-25
SE462043B true SE462043B (sv) 1990-04-30

Family

ID=10964931

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8405331A SE462043B (sv) 1983-10-25 1984-10-25 1,3 oxazino 4,3-a isokinolinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner innehaallande dem

Country Status (15)

Country Link
US (1) US4623647A (de)
JP (1) JPS60115589A (de)
AT (1) AT387576B (de)
BE (1) BE900883A (de)
CA (1) CA1238905A (de)
CH (1) CH664570A5 (de)
DE (1) DE3439131A1 (de)
DK (1) DK508684A (de)
FI (1) FI76806C (de)
FR (1) FR2553776B1 (de)
GB (1) GB2148887B (de)
HU (1) HU190458B (de)
IT (1) IT1213235B (de)
NL (1) NL8403251A (de)
SE (1) SE462043B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU191301B (en) * 1984-03-23 1987-02-27 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for preparing 1-/hydroxy-methyl/-1,6,7,11b-tetrahydro-2h,4h-/1,3/-oxazino- or -thiazino/4,3-a/isoquinoline -derivatives
KR100429356B1 (ko) * 2001-04-23 2004-05-31 조수동 다약제 내성 극복 이소퀴놀린계 화합물 및 그 제조방법
US7264709B2 (en) * 2004-09-21 2007-09-04 Siemens Water Technologies Holding Corp. Method and apparatus for conditioning a sensor for measuring oxidation reduction potential

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1094470A (en) * 1965-08-19 1967-12-13 Merck Ag E Isoquinoline derivatives and preparation thereof
US3389141A (en) * 1966-05-16 1968-06-18 Bristol Myers Co 1-beta-aryloxyethyltetrahydro-isoquinolines
IE37234B1 (en) * 1972-02-14 1977-06-08 Ayerst Mckenna & Harrison Fused-ring indole derivatives

Also Published As

Publication number Publication date
CA1238905A (en) 1988-07-05
ATA339884A (de) 1988-07-15
BE900883A (fr) 1985-04-24
DK508684A (da) 1985-04-26
DK508684D0 (da) 1984-10-25
GB2148887B (en) 1987-02-25
US4623647A (en) 1986-11-18
IT8423305A0 (it) 1984-10-25
FI844187L (fi) 1985-04-26
DE3439131A1 (de) 1985-05-02
FI844187A0 (fi) 1984-10-25
FI76806C (fi) 1988-12-12
GB2148887A (en) 1985-06-05
FI76806B (fi) 1988-08-31
FR2553776A1 (fr) 1985-04-26
IT1213235B (it) 1989-12-14
FR2553776B1 (fr) 1987-04-24
SE8405338D0 (sv) 1984-10-25
CH664570A5 (de) 1988-03-15
HU190458B (en) 1986-09-29
NL8403251A (nl) 1985-05-17
GB8425250D0 (en) 1984-11-14
JPS60115589A (ja) 1985-06-22
AT387576B (de) 1989-02-10

Similar Documents

Publication Publication Date Title
CA3164134A1 (en) Substituted tetrahydrofurans as modulators of sodium channels
RU2125051C1 (ru) Производные дифенила, производное фенилпиперазина и способ лечения
EP4347583A1 (de) Substituierte tetrahydrofurananaloga als modulatoren von natriumkanälen
JP3188418B2 (ja) ３−（縮合環置換）フェニル−５β−アミドメチルオキサゾリジン−２−オン類および３−（窒素原子置換）フェニル−５β−アミドメチルオキサゾリジン−２−オン類
AU650182B2 (en) Novel azaheterocyclylmethyl-chromans
JP2024522292A (ja) ナトリウムチャネルのモジュレーターとしてのｎ－（ヒドロキシアルキル（ヘテロ）アリール）テトラヒドロフランカルボキサミド
CA3221788A1 (en) Substituted tetrahydrofuran-2-carboxamides as modulators of sodium channels
CA3221939A1 (en) N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamide analogs as modulators of sodium channels
EP3504214B1 (de) Kondensierte tricyclische verbindungen zur behandlung von orthomyxovirusinfektionen
TW200924760A (en) Gamma secretase modulators
JPH10511381A (ja) スピロケタール誘導体、該誘導体を含有する組成物、及び該誘導体の治療薬としての使用
KR101800919B1 (ko) 크로먼 유도체들
EP0402156A1 (de) 2,5-Diaryltetrahydrofurane und deren Analoge als PAF-Antagonisten
SE462043B (sv) 1,3 oxazino 4,3-a isokinolinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner innehaallande dem
AU729468B2 (en) Novel amide derivatives and medicinal compositions thereof
JP2002500658A (ja) ２−アミノ−７−（１−置換−２−ヒドロキシエチル）−３，５−ジヒドロピロロ［３，２−ｄ］ピリミジン−４−オン
HU201006B (en) Process for producing thioformamide derivatives and pharmaceutical compositions comprising same as active ingredient
US6096761A (en) Esters of 3-hydroxy-piperidinemethanol derivatives
HU188328B (en) Process for preparing 3'-substituted-5'-/2-amino-4-pyridyl/-1',2',4'-triazole derivatives
CA2228286A1 (en) Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives
HK40055239A (en) Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
CA2012656A1 (en) Preparation and use of pyridinyl-1-pyrazole-1-alkanamides as antiarrhythmic agents
OA21895A (en) N-(HydroxyalkyI (Hetero) Aryl) Tetrahydrofuran carboxamides as modulators of sodium channels.
SE456585B (sv) 2h-azeto (2,1-a)-isokinolinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem
EP2201007A1 (de) Cannabinoid-rezeptorliganden

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8405331-3

Effective date: 19920510

Format of ref document f/p: F